{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:03:56Z","timestamp":1778569436631,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Serogroup B meningococcus (MenB) is a leading cause of meningitis and sepsis across the world and vaccination is the most effective way to protect against this disease. 4CMenB is a multi-component vaccine against MenB, which is now licensed for use in subjects &gt;2 months of age in several countries. In this study, we describe the development and use of an ad hoc protein microarray to study the immune response induced by the three major 4CMenB antigenic components (fHbp, NHBA and NadA) in individual sera from vaccinated infants, adolescents and adults. The resulting 4CMenB protein antigen fingerprinting allowed the identification of specific human antibody repertoire correlating with the bactericidal response elicited in each subject. This work represents an example of epitope mapping of the immune response induced by a multicomponent vaccine in different age groups with the identification of protective signatures. It shows the high flexibility of this microarray based methodology in terms of high-throughput information and minimal volume of biological samples needed.<\/jats:p>","DOI":"10.1038\/s41467-020-18791-0","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T10:05:05Z","timestamp":1601892305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-2630","authenticated-orcid":false,"given":"E.","family":"Bartolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Borgogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-2522","authenticated-orcid":false,"given":"M.","family":"Bruttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Iozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Petracca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7771-4736","authenticated-orcid":false,"given":"S.","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Donati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Torricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Domina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-1337","authenticated-orcid":false,"given":"C.","family":"Beninati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Teti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2205-5195","authenticated-orcid":false,"given":"F.","family":"Felici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-254X","authenticated-orcid":false,"given":"R.","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Masignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-9241","authenticated-orcid":false,"given":"D.","family":"Maione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"18791_CR1","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","volume":"19","author":"R Rappuoli","year":"2001","unstructured":"Rappuoli, R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19, 2688 (2001).","journal-title":"Vaccine"},{"key":"18791_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"M Pizza","year":"2000","unstructured":"Pizza, M. et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816 (2000).","journal-title":"Science"},{"issue":"Jun","key":"18791_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.4161\/hv.7.6.15482","volume":"7","author":"D Toneatto","year":"2011","unstructured":"Toneatto, D. et al. The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans. Hum. Vaccines 7(Jun), 646 (2011).","journal-title":"Hum. Vaccines"},{"key":"18791_CR4","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"MM Giuliani","year":"2006","unstructured":"Giuliani, M. M. et al. A universal vaccine for serogroup B meningococcus. Proc. Natl Acad. Sci. USA 103, 10834 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/hv.4.2.4871","volume":"4","author":"L van Alphen","year":"2008","unstructured":"van Alphen, L. & van den Dobbelsteen, G. Meningococcal B vaccine development and evaluation of efficacy. Hum. Vaccines 4, 158 (2008).","journal-title":"Hum. Vaccines"},{"key":"18791_CR6","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","volume":"23","author":"R Borrow","year":"2005","unstructured":"Borrow, R., Balmer, P. & Miller, E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23, 2222 (2005).","journal-title":"Vaccine"},{"key":"18791_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri2508","volume":"9","author":"CA Siegrist","year":"2009","unstructured":"Siegrist, C. A. & Aspinall, R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9, 185 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"18791_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri1394","volume":"4","author":"B Adkins","year":"2004","unstructured":"Adkins, B., Leclerc, C. & Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"18791_CR9","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.molimm.2009.04.009","volume":"46","author":"J Du","year":"2009","unstructured":"Du, J., Yang, H., Guo, Y. & Ding, J. Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20. Mol. Immunol. 46, 2419 (2009).","journal-title":"Mol. Immunol."},{"key":"18791_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature01392","volume":"421","author":"HS Cho","year":"2003","unstructured":"Cho, H. S. et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421, 756 (2003).","journal-title":"Nature"},{"key":"18791_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-59745-450-6_3","volume":"524","author":"O Rosen","year":"2009","unstructured":"Rosen, O. & Anglister, J. Epitope mapping of antibody-antigen complexes by nuclear magnetic resonance spectroscopy. Methods Mol. Biol. 524, 37 (2009).","journal-title":"Methods Mol. Biol."},{"key":"18791_CR12","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1073\/pnas.0711731105","volume":"105","author":"W Hoyer","year":"2008","unstructured":"Hoyer, W., Gronwall, C., Jonsson, A., Stahl, S. & Hard, T. Stabilization of a beta-hairpin in monomeric Alzheimer\u2019s amyloid-beta peptide inhibits amyloid formation. Proc. Natl Acad. Sci. USA 105, 5099 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR13","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1073\/pnas.1222845110","volume":"110","author":"E Malito","year":"2013","unstructured":"Malito, E. et al. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc. Natl Acad. Sci. USA 110, 3304 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1096\/fj.13-239012","volume":"28","author":"A Faleri","year":"2014","unstructured":"Faleri, A. et al. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties. FASEB J. 28, 1644 (2014).","journal-title":"FASEB J."},{"key":"18791_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","volume":"228","author":"GP Smith","year":"1985","unstructured":"Smith, G. P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315 (1985).","journal-title":"Science"},{"key":"18791_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ijc.11269","volume":"106","author":"O Minenkova","year":"2003","unstructured":"Minenkova, O. et al. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int. J. Cancer 106, 534 (2003).","journal-title":"Int. J. Cancer"},{"key":"18791_CR17","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/molecules16043089","volume":"16","author":"E Beghetto","year":"2011","unstructured":"Beghetto, E. & Gargano, N. Lambda-display: a powerful tool for antigen discovery. Molecules 16, 3089 (2011).","journal-title":"Molecules"},{"key":"18791_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1574-6968.2006.00360.x","volume":"262","author":"E Beghetto","year":"2006","unstructured":"Beghetto, E. et al. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol. Lett. 262, 14 (2006).","journal-title":"FEMS Microbiol. Lett."},{"key":"18791_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1042\/bj1970507","volume":"197","author":"AL Kazim","year":"1981","unstructured":"Kazim, A. L. & Atassi, M. Z. Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin. Biochem. J. 197, 507 (1981).","journal-title":"Biochem. J."},{"key":"18791_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1128\/CVI.00190-15","volume":"22","author":"OH Negm","year":"2015","unstructured":"Negm, O. H. et al. Profiling humoral immune responses to clostridium difficile-specific antigens by protein microarray analysis. Clin. Vacc. Immunol. 22, 1033\u20131039 https:\/\/doi.org\/10.1128\/CVI.00190-15 (2015).","journal-title":"Clin. Vacc. Immunol."},{"key":"18791_CR21","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.1128\/JVI.77.20.11125-11138.2003","volume":"77","author":"HE Neuman de Vegvar","year":"2003","unstructured":"Neuman de Vegvar, H. E. et al. Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J. Virol. 77, 11125 (2003).","journal-title":"J. Virol."},{"key":"18791_CR22","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/nm.2913","volume":"18","author":"JV Price","year":"2012","unstructured":"Price, J. V. et al. On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. Nat. Med. 18, 1434 (2012).","journal-title":"Nat. Med."},{"key":"18791_CR23","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.21269","volume":"52","author":"W Hueber","year":"2005","unstructured":"Hueber, W. et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52, 2645 (2005).","journal-title":"Arthritis Rheum."},{"key":"18791_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nm0302-295","volume":"8","author":"WH Robinson","year":"2002","unstructured":"Robinson, W. H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295 (2002).","journal-title":"Nat. Med."},{"key":"18791_CR25","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1073\/pnas.1111413109","volume":"109","author":"SJ Lee","year":"2012","unstructured":"Lee, S. J. et al. Identification of a common immune signature in murine and human systemic Salmonellosis. Proc. Natl Acad. Sci. USA 109, 4998 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2019.00114","volume":"10","author":"F Rigat","year":"2019","unstructured":"Rigat, F. et al. Retrospective identification of a Broad IgG repertoire differentiating patients with S. aureus skin and soft tissue infections from controls. Front. Immunol. 10, 114 (2019).","journal-title":"Front. Immunol."},{"key":"18791_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43139-0","volume":"9","author":"AM Awanye","year":"2019","unstructured":"Awanye, A. M. et al. Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis. Sci. Rep. 9, 6843 (2019).","journal-title":"Sci. Rep."},{"key":"18791_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1128\/JVI.01706-07","volume":"82","author":"DH Davies","year":"2008","unstructured":"Davies, D. H. et al. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol. 82, 652 (2008).","journal-title":"J. Virol."},{"key":"18791_CR29","doi-asserted-by":"publisher","first-page":"e64555","DOI":"10.1371\/journal.pone.0064555","volume":"8","author":"JV Price","year":"2013","unstructured":"Price, J. V. et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS ONE 8, e64555 (2013).","journal-title":"PLoS ONE"},{"key":"18791_CR30","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/pmic.200401097","volume":"5","author":"S Steller","year":"2005","unstructured":"Steller, S. et al. Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Proteomics 5, 2048 (2005).","journal-title":"Proteomics"},{"key":"18791_CR31","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1073\/pnas.1309390110","volume":"110","author":"JB Legutki","year":"2013","unstructured":"Legutki, J. B. & Johnston, S. A. Immunosignatures can predict vaccine efficacy. Proc. Natl Acad. Sci. USA 110, 18614 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep31458","volume":"6","author":"M Domina","year":"2016","unstructured":"Domina, M. et al. Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform. Sci. Rep. 6, 31458 (2016).","journal-title":"Sci. Rep."},{"key":"18791_CR33","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","volume":"458","author":"MC Schneider","year":"2009","unstructured":"Schneider, M. C. et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890 (2009).","journal-title":"Nature"},{"key":"18791_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/JB.00430-10","volume":"193","author":"R Tavano","year":"2011","unstructured":"Tavano, R. et al. Mapping of the Neisseria meningitidis NadA cell-binding site: relevance of predicted {alpha}-helices in the NH2-terminal and dimeric coiled-coil regions. J. Bacteriol. 193, 107 (2011).","journal-title":"J. Bacteriol."},{"key":"18791_CR35","doi-asserted-by":"publisher","first-page":"17128","DOI":"10.1073\/pnas.1419686111","volume":"111","author":"E Malito","year":"2014","unstructured":"Malito, E. et al. Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody. Proc. Natl Acad. Sci. USA 111, 17128 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18791_CR36","doi-asserted-by":"publisher","first-page":"41767","DOI":"10.1074\/jbc.M111.289314","volume":"286","author":"V Esposito","year":"2011","unstructured":"Esposito, V. et al. Structure of the C-terminal domain of Neisseria heparin binding antigen (NHBA), one of the main antigens of a novel vaccine against Neisseria meningitidis. J. Biol. Chem. 286, 41767 (2011).","journal-title":"J. Biol. Chem."},{"key":"18791_CR37","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","volume":"30","author":"D Serruto","year":"2012","unstructured":"Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M. & Rappuoli, R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 30, B87 (2012).","journal-title":"Vaccine"},{"key":"18791_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1096\/fj.15-273813","volume":"30","author":"I Bertoldi","year":"2016","unstructured":"Bertoldi, I. et al. Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components. FASEB J. 30, 93\u2013101 http:\/\/www.fasebj.org (2016).","journal-title":"FASEB J."},{"key":"18791_CR39","doi-asserted-by":"publisher","first-page":"e0160702","DOI":"10.1371\/journal.pone.0160702","volume":"11","author":"M Domina","year":"2016","unstructured":"Domina, M. et al. Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries. PLoS ONE 11, e0160702 (2016).","journal-title":"PLoS ONE"},{"key":"18791_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22057-7","volume":"8","author":"M Giuliani","year":"2018","unstructured":"Giuliani, M. et al. Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes. Sci. Rep. 8, 3700 (2018).","journal-title":"Sci. Rep."},{"issue":"Jul","key":"18791_CR41","doi-asserted-by":"publisher","first-page":"e6332","DOI":"10.1371\/journal.pone.0006332","volume":"4","author":"M Bombaci","year":"2009","unstructured":"Bombaci, M. et al. Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens. PLoS ONE 4(Jul), e6332 (2009).","journal-title":"PLoS ONE"},{"key":"18791_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","volume":"74","author":"M O\u2019Ryan","year":"2014","unstructured":"O\u2019Ryan, M., Stoddard, J., Toneatto, D., Wassil, J. & Dull, P. M. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs 74, 15 (2014).","journal-title":"Drugs"},{"key":"18791_CR43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","volume":"379","author":"ME Santolaya","year":"2012","unstructured":"Santolaya, M. E. et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study. Lancet 379, 617 (2012).","journal-title":"Lancet"},{"key":"18791_CR44","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1503\/cmaj.130257","volume":"185","author":"MD Snape","year":"2013","unstructured":"Snape, M. D. et al. Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose. Can. Med. Assoc. J. 185, E715 (2013).","journal-title":"Can. Med. Assoc. J."},{"key":"18791_CR45","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1097\/INF.0000000000001056","volume":"35","author":"MD Snape","year":"2016","unstructured":"Snape, M. D. et al. Persistence of bactericidal antibodies after infant serogroup B meningococcal immunization and booster dose response at 12, 18 or 24 months of age. Pediatr. Infect. Dis. J. 35, e113 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"18791_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1128\/CVI.00304-10","volume":"18","author":"A Kimura","year":"2011","unstructured":"Kimura, A., Toneatto, D., Kleinschmidt, A., Wang, H. & Dull, P. Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Clin. Vaccin. Immunol. 18, 483 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"18791_CR47","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","volume":"27","author":"S Bambini","year":"2009","unstructured":"Bambini, S. et al. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 27, 2794 (2009).","journal-title":"Vaccine"},{"key":"18791_CR48","doi-asserted-by":"publisher","first-page":"e00163","DOI":"10.1128\/mBio.00163-13","volume":"4","author":"A Muzzi","year":"2013","unstructured":"Muzzi, A., Mora, M., Pizza, M., Rappuoli, R. & Donati, C. Conservation of meningococcal antigens in the genus Neisseria. MBio 4, e00163 (2013).","journal-title":"MBio"},{"key":"18791_CR49","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","volume":"24","author":"S Jacobsson","year":"2006","unstructured":"Jacobsson, S. et al. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine 24, 2161 (2006).","journal-title":"Vaccine"},{"key":"18791_CR50","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","volume":"129","author":"I Goldschneider","year":"1969","unstructured":"Goldschneider, I., Gotschlich, E. C. & Artenstein, M. S. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129, 1327 (1969).","journal-title":"J. Exp. Med."},{"key":"18791_CR51","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","author":"V Masignani","year":"2003","unstructured":"Masignani, V. et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197, 789 (2003).","journal-title":"J. Exp. Med."},{"key":"18791_CR52","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"LD Fletcher","year":"2004","unstructured":"Fletcher, L. D. et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect. Immun. 72, 2088 (2004).","journal-title":"Infect. Immun."},{"key":"18791_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2012.85","volume":"307","author":"N Gossger","year":"2012","unstructured":"Gossger, N. et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. J. Am. Med. Assoc. 307, 573 (2012).","journal-title":"J. Am. Med. Assoc."},{"key":"18791_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/19420862.2016.1158371","volume":"8","author":"VL Cariccio","year":"2016","unstructured":"Cariccio, V. L. et al. Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology. MAbs 8, 741 (2016).","journal-title":"MAbs"},{"key":"18791_CR55","doi-asserted-by":"publisher","first-page":"e114159","DOI":"10.1371\/journal.pone.0114159","volume":"9","author":"M Domina","year":"2014","unstructured":"Domina, M. et al. Rapid profiling of the antigen regions recognized by serum antibodies using massively parallel sequencing of antigen-specific libraries. PLoS ONE 9, e114159 (2014).","journal-title":"PLoS ONE"},{"key":"18791_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-59745-196-3_6","volume":"498","author":"HE Klock","year":"2009","unstructured":"Klock, H. E. & Lesley, S. A. The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol. Biol. 498, 91 (2009).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18791-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18791-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18791-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T01:25:18Z","timestamp":1670289918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18791-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18791"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18791-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was sponsored by Novartis Vaccines, now acquired by the GSK group of companies. All authors have declared the following interests: E. Ba, E. Bo, A.M., M.G., S.I., R.P., M.M., S.B., S.M., C. Br, C.D., G. To, S.G., R.R., F.C., G.D.G., V.M., M.P. and D.M. were permanent employees of Novartis Vaccines at the time of the study. M.B. was holding a PhD studentship and collaborated with GSK at the time of the study as part of his PhD training. Following the acquisition of Novartis Vaccines by the GSK group of companies in March, 2015, E. Ba, E. Bo, A.M., M.G., S.I., R.P., S.B., S.M., C. Br, G. To, S.G., R.R., G.D.G., V.M., M.P. and D.M. are now permanent employees of the GSK group of companies. M.B. is now permanent employee of Polo GGB. C.D. is now permanent employee of Fondazione Edmund Mach, San Michele all\u2019Adige. C. Be and G. Te are Professors, and M.D. was holding a PhD studentship at the time of the study, at the University of Messina. F.F. is Professor at the University of Molise. F.C. is now permanent employee of US Department of Health & Human services. G.D.G. own shares and stock options of the GSK group of companies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4994"}}